Alamar Biosciences unveils NULISAseq Inflammation Panel AQ
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced the launch of the NULISAseq™ Inflammation Panel AQ, setting a new standard in profiling the…
Lire la suite / Read more